Condition

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 1 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting0

Common interventions12

Lead sponsors shown1

Clinical trials

1 shown

Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C TrialNCT07723235 · 2026-10-10

NOT_YET_RECRUITING

Common interventions

Aerobic ExerciseOTHER1 Biospecimen CollectionPROCEDURE1 Dietary InterventionOTHER1 DiscussionOTHER1 Goal SettingOTHER1 Internet-Based InterventionOTHER1 Medical Device Usage and EvaluationOTHER1 Questionnaire AdministrationOTHER1 Resistance TrainingOTHER1 Smartphone Application-based InterventionBEHAVIORAL1 Supportive CareOTHER1 Tailored InterventionPROCEDURE1

Leading sponsors

Ohio State University Comprehensive Cancer Center 1

Trial status mix

NOT_YET_RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.